# EDGAR Filing Document

**Accession Number:** 0001835022
**File Stem:** 0001193125-26-115931
**Filing Date:** 2026-3
**Character Count:** 1953
**Document Hash:** 85a050839181b6af02e054d9aff6478c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-115931.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0001193125-26-115931

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260319

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Coya Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001835022
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 12645 MEMORIAL DR., SUITE F1 #305
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77024
- **BUSINESS PHONE:** 650.739.3939

**MAIL ADDRESS:**
- **STREET 1:** 12645 MEMORIAL DR., SUITE F1 #305
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77024

March 19, 2026

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Coya Therapeutics, Inc. (the "Company")**  |

---

**Registration Statement on Form S-3 (File No. 333-294315)**

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the "Registration Statement") be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on March 20, 2026, or as soon as practicable thereafter.

Please call Perry Laub of Lowenstein Sandler LLP at (212) 419-5914 to confirm the effectiveness of the Registration Statement or with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **COYA THERAPEUTICS, INC.** | **COYA THERAPEUTICS, INC.** |
| By: | */s/ Arun Swaminathan* |
| Name: | Arun Swaminathan |
| Title: | Chief Executive Officer<br> *(Principal Executive Officer)* |

---